Skip to content
MARKET
NIFTY 5023842.75+127.30+0.54%
SENSEX78553.20+418.45+0.54%
NIFTY BANK51236.80-89.15-0.17%
NIFTY IT33156.40+245.60+0.75%
NIFTY PHARMA19872.35+56.20+0.28%
NIFTY AUTO23145.90-112.40-0.48%
NIFTY FMCG56234.15+178.90+0.32%
INDIA VIX13.42-0.38-2.75%
NIFTY 5023842.75+127.30+0.54%
SENSEX78553.20+418.45+0.54%
NIFTY BANK51236.80-89.15-0.17%
NIFTY IT33156.40+245.60+0.75%
NIFTY PHARMA19872.35+56.20+0.28%
NIFTY AUTO23145.90-112.40-0.48%
NIFTY FMCG56234.15+178.90+0.32%
INDIA VIX13.42-0.38-2.75%
Barakfi
⌕/

Menu

⌂Home⌕Screener⊞Compare
TermsPrivacyDisclaimerShariah
Theme
Screener
WatchlistPortfolio
Log inGet started
⌂Home⌕Screener☆Watchlist▦Portfolio
Home/Screener/AMGN
USHealthcareIndia
AMGN logo

Amgen Inc.

Non-Compliant
₹348

-1.48% today · Day ₹346 – ₹354 · Vol 15.4L · Yahoo chart

2/6Pass

This stock doesn't meet 2 Shariah rules. See below to understand why.

58/100
Non-Compliant

This stock doesn't meet 2 Shariah rules. See below to understand why.

Market Cap₹1.9 L
Revenue₹36,751
Total Debt₹54,604
Debt / Mcap32.35%
Non-Halal Income6.99%
SectorHealthcare
✦
Healthcare›Healthcare
▲
Large Cap›Market cap of ₹1.9 L
⇅
Higher Risk›Debt ratio 32.35%
Ad
Price Chart
Loading chart...
52-Week Range67% from low
₹261₹348₹391
52-Week Low₹261
52-Week High₹391
Prev Close₹353
Volume15.4 L

Multi-Methodology Screening

Screened against 4 international Shariah standards

ConsensusNon-Compliant0/4 pass
S&P Shariah IndicesNon-Compliant
Debt Ratio32.4%/ 33.0%
Non-Halal Income7.0%/ 5.0%
Interest Income7.0%/ 5.0%
Receivables5.1%/ 33.0%
Cash & IB Securities10.1%/ 33.0%
SectorAllowed

Non-permissible income is 7.0% of revenue, exceeding the 5% limit under S&P.

Interest income is 7.0% of revenue, exceeding the 5% limit under S&P.

AAOIFI StandardsNon-Compliant
Debt Ratio60.3%/ 30.0%
Non-Halal Income7.0%/ 5.0%
Interest Income7.0%/ 5.0%
Receivables10.6%/ 49.0%
Cash & IB Securities10.1%/ 30.0%
SectorAllowed

Debt is 60.3% of total assets, exceeding the 30% threshold set by AAOIFI.

Debt is 60.3% of current total assets, exceeding the 30% threshold.

Non-permissible income is 7.0% of revenue, exceeding the 5% limit under AAOIFI.

FTSE Yasaar (Maxis)Non-Compliant
Debt Ratio60.3%/ 33.0%
Non-Halal Income7.0%/ 5.0%
Interest Income7.0%/ 5.0%
Receivables10.6%/ 50.0%
Cash & IB Securities10.1%/ 33.0%
SectorAllowed

Debt is 60.3% of total assets, exceeding the 33% threshold set by FTSE.

Debt is 60.3% of current total assets, exceeding the 33% threshold.

Non-permissible income is 7.0% of revenue, exceeding the 5% limit under FTSE.

Khatkhatay Independent NormsNon-Compliant
Debt Ratio60.3%/ 25.0%
Non-Halal Income7.0%/ 5.0%
Interest Income7.0%/ 5.0%
Receivables10.6%/ 100.0%
Cash & IB Securities10.1%/ 10.0%
SectorAllowed

Debt is 60.3% of total assets, exceeding the 25% threshold set by Independent.

Debt is 60.3% of current total assets, exceeding the 25% threshold.

Non-permissible income is 7.0% of revenue, exceeding the 5% limit under Independent.

Each methodology uses different denominators and thresholds. A stock may be compliant under one standard but not another. The consensus reflects the majority verdict across all three.

Compliance check

Green = safe, amber = close to limit, red = over the limit

Debt level
32.35%
How much debt the company carriesLimit: 33.00%
Current debt
29.11%
Debt compared to current company valueLimit: 33.00%
Income purity
6.99%
How much income comes from non-halal sourcesLimit: 5.00%
Interest earned
6.99%

Similar stocks

Other stocks in Healthcare

LLY logo
LLYEli Lilly and Company
Cautious
₹936-1.48%
₹8.4 L
JNJ logo
JNJJohnson & Johnson
Cautious
₹243-1.48%
₹5.9 L
ABBV logo
ABBVAbbVie Inc.
Cautious
₹209-1.48%
₹3.7 L
MRK logo
MRKMerck & Co., Inc.
Interest income as portion of total revenueLimit: 5.00%
Money owed to company
5.10%
Outstanding receivables compared to company valueLimit: 33.00%
Cash & interest-bearing
10.08%
Cash and interest-bearing securities as a portion of total assetsLimit: 33.00%
Fixed Assets / Total Assets
8.74%
Asset composition indicatorNo hard threshold

Screening rules

Why it screened this way

✗

Non-permissible income is 7.0% of revenue, exceeding the 5% limit under S&P.

✗

Interest income is 7.0% of revenue, exceeding the 5% limit under S&P.

Screening results indicate whether this stock meets specific methodology criteria. They do not constitute a fatwa or religious ruling. Consult a qualified Shariah scholar for definitive guidance. View methodology
Cautious
₹121-1.48%
₹3.0 L